As of 2025-11-04, the Fair Value of Appili Therapeutics Inc (APLI.TO) is -0.10 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.03 CAD, the upside of Appili Therapeutics Inc is -515.17%.
With the market price of 0.03 CAD and our fair value calculation, Appili Therapeutics Inc (APLI.TO) is not a good investment. Investing in APLI.TO stocks now will result in a potential loss of 515.17%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 5Y Avg | |
| Net income | -14.33 | -25.12 | -9.24 | -3.78 | -2.62 | -11.02 |
| YoY growth | -164.39% | -75.30% | 63.22% | 59.08% | 30.58% | -17.36% |
| Market Cap (mil) | 3.03 |
| P/E | |
| Forward P/E |
| EPS | -0.02 |
| Avg earnings growth rate | -17.36% |
| TTM earnings | -2.52 |